The four strategies outlined include the following:
- Establish a unique device identification system and promote its incorporation into electronic health information
- Promote the development of national and international device registries for selected products
- Modernize adverse event reporting and analysis
- Develop and use new methods for evidence generation, synthesis and appraisal
The FDA will host four public meetings this month to garner public feedback.